Cronos Group Inc. (CRON)
NASDAQ: CRON · IEX Real-Time Price · USD
2.680
+0.020 (0.75%)
At close: May 3, 2024, 4:00 PM
2.700
+0.020 (0.75%)
After-hours: May 3, 2024, 6:39 PM EDT

Cronos Group Revenue

In the year 2023, Cronos Group had annual revenue of $87.24M with 0.57% growth. Revenue in the quarter ending December 31, 2023 was $23.92M with 8.54% year-over-year growth.

Revenue (ttm)
$87.24M
Revenue Growth
+0.57%
P/S Ratio
11.60
Revenue / Employee
$245,059
Employees
356
Market Cap
1.02B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202387.24M492.00K0.57%
Dec 31, 202286.75M22.19M34.37%
Dec 31, 202164.56M17.84M38.19%
Dec 31, 202046.72M22.97M96.71%
Dec 31, 201923.75M11.63M95.94%
Dec 31, 201812.12M8.97M285.16%
Dec 31, 20173.15M2.72M638.69%
Dec 31, 2016426.03K--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Alignment Healthcare 1.82B
AtriCure 399.25M
MiMedx Group 334.51M
Canopy Growth 248.53M
Arcutis Biotherapeutics 59.61M
AbCellera Biologics 38.03M
Silence Therapeutics 32.12M
Bicycle Therapeutics 26.98M
Revenue Rankings